Rezanka et al., 2007 - Google Patents
Medicinal use of lincosamides and microbial resistance to themRezanka et al., 2007
View PDF- Document ID
- 1317313100488969399
- Author
- Rezanka T
- Spizek J
- Sigler K
- Publication year
- Publication venue
- Anti-Infective Agents in Medicinal ChemistryChemistry-Anti-Infective Agents)
External Links
Snippet
Lincomycin and its derivatives are antibiotics exhibiting biological activity against bacteria, especially Grampositive ones, and also protozoans. Lincomycin and its semi-synthetic chlorinated derivative clindamycin are widely used in clinical practice. Both antibiotics are …
- 229940041028 Lincosamides 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022203288B2 (en) | Antimicrobial therapy | |
| Spížek et al. | Lincomycin, clindamycin and their applications | |
| Mahajan et al. | Antibacterial agents from actinomycetes-a review | |
| Daly et al. | Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound | |
| EP2222309B1 (en) | Antibiotic macrocycle compounds and methods of manufacture and use thereof | |
| WO2012173452A1 (en) | Antimicrobial agent made of ginsenoside compound k or derivatives thereof | |
| US20040127403A1 (en) | Methods for treating and preventing Gram-positive bacteremias | |
| Rezanka et al. | Medicinal use of lincosamides and microbial resistance to them | |
| US6951840B2 (en) | Lipoglycopeptide antibiotics | |
| EP2500022B1 (en) | Antibacterial agent for drug-resistant bacteria and use of same | |
| EP1928900A1 (en) | Variants of the lantibiotic mersacidin and their use | |
| US5939279A (en) | Inhibition of bacterial binding by high-mannose oligosaccharides | |
| Guay | Update on clindamycin in the management of bacterial, fungal and protozoal infections | |
| JP2014516950A (en) | Mastitis treatment | |
| JPH01175997A (en) | Glycosylated glycopeptide | |
| US12016874B2 (en) | Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections | |
| Allen | Nonclassical targets for antibacterial agents | |
| US7595328B2 (en) | Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria | |
| US20100168001A1 (en) | Method for Preventing and/or Treating Articles or Media Contaminated With Bacteria of the Legionelle Genus | |
| US8691773B2 (en) | Peptide compound with biological activity, its preparation and its applications | |
| US20070281992A1 (en) | Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof | |
| Katara et al. | Role of bacteria and fungi in antibiotic production | |
| Hussain et al. | Lincosamide and glycopeptide antibiotics | |
| WO2017082709A1 (en) | Method for treating hemolytic uremic syndrome | |
| JP2010519301A (en) | How to treat an infection |